Katherine Eban, an investigative journalist, is a Fortune magazine contributor and Andrew Carnegie fellow. Her narrative, deeply reported articles on pharmaceutical counterfeiting, gun trafficking, and coercive interrogations by the CIA, have won international attention and numerous awards. She lectures frequently on the topic of pharmaceutical integrity. Bottle of Lies: The Inside Story of the Generic Drug Boom, which she worked on for five years and reported on four continents, is her second book. Educated at Brown University and Oxford, where she was a Rhodes Scholar, she lives in Brooklyn with her husband, two daughters and Newfoundland dog Romeo.
Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true?
Katherine Eban’s Bottle of Lies exposes the deceit behind generic-drug manufacturing—and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects.
The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?
A decade-long investigation with international sweep, high-stakes brinkmanship and big money at its core, Bottle of Lies reveals how the world’s greatest public-health innovation has become one of its most astonishing swindles.
##在这本书之前,我对仿制药的了解可以用两句话讲完:理想很丰满,现实很骨感。 一方面,我理解为什么我们需要仿制药。广大穷人(包括我自己)都渴望推动仿制药的出现——因为救命的原研药实在太贵了,尤其是在美国医疗市场的环境中。 另一方面,我也明白为什么在医保改革之后,...
评分 评分 评分##首先,非常感谢作者在经过大量的访谈和研究之后写出这么一本精彩的书,很不易。其次,作者选择的话题让我震惊。真的是用震惊来形容都不过!都感觉不象是非虚构作品,而是一本惊悚小说。印度制药界是没有良心可言的,他们认为撒谎,作假是正常的,因为整个社会都是这样,有什么好奇怪的。就算是铁证如山,他们仍旧可以平静地看着你的眼睛,说,没有啊?这药好好的呀。FDA实在是机构臃肿,办事非常不利索。如果没有最出的whistler blower和自己的好员工,那么这个药厂的丑闻还不知道什么时候才能被揭露,而又会又多少病人因为药的不合格而死去。最后,这本书写得非常棒,文字功底厚,结构条例清晰。强烈推荐给任何对健康重视的人士。
评分##在这本书之前,我对仿制药的了解可以用两句话讲完:理想很丰满,现实很骨感。 一方面,我理解为什么我们需要仿制药。广大穷人(包括我自己)都渴望推动仿制药的出现——因为救命的原研药实在太贵了,尤其是在美国医疗市场的环境中。 另一方面,我也明白为什么在医保改革之后,...
本站所有内容均为互联网搜索引擎提供的公开搜索信息,本站不存储任何数据与内容,任何内容与数据均与本站无关,如有需要请联系相关搜索引擎包括但不限于百度,google,bing,sogou 等
© 2025 book.idnshop.cc All Rights Reserved. 静思书屋 版权所有